
|Videos|September 30, 2017
Long-Acting Injectable: An Exciting New Option for HIV Prevention
Author(s)Contagion® Editorial Staff
Alex Rinehart, PhD, explains how the development of a long-acting injectable offers a new preventive option for HIV.
Advertisement
Alex Rinehart, PhD, Director, Global Prevention Strategy, ViiV Healthcare, explains how the development of a long-acting injectable could potentially offer a new preventive option for individuals at risk for HIV.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Contagion Live
1
The Potential Ramifications of Changing the MMR Vaccine Into 3 Separate Immunizations
2
How New “Shared Clinical Decision Making” Vaccine Category Will Likely Increase Children’s Disease
3
Cascading Effects of Executive Order on Childhood Vaccines
4
This Week's Top 5 Infectious Disease News Stories: August 8-August 14, 2026
5



























































































































































